title: [Evaluation and estimation of entrance skin dose in patients during diagnostic and interventional radiology procedures].
abstract: A study was performed to evaluate the total entrance skin dose (ESD) of patients during diagnostic and interventional radiology procedures (IVR) and to estimate ESD with body mass index (BMI) and fluoroscopy time. The study included 26 cases of transcatheter arterial embolization therapy (TAE) for hepatocellular carcinoma (HCC) and 19 cases of diagnostic digital subtraction angiography (DSA) for HCC. The ESD of patients was evaluated with a zinc-cadmium sensor linked to a digital counter (SDM: skin dose monitor). Exposure doses were measured with SDM attached to the front of the X-ray beam-limiting device like a dose area product monitor. ESD was calculated from the measured exposure dose. In 26 TAE for HCC, ESD was 1793.7+/-739.1 mGy, with the mean fluoroscopic time of 23.5 minutes and 4.4 DSA acquisitions. The fluoroscopic dose rate was 52.4+/-11.5 mGy/min. In 19 diagnostic DSA for HCC, ESD was 962.9+/-375.2 mGy, with the mean fluoroscopic time of 11.1 minutes and 4.0 DSA acquisitions. The fluoroscopic dose rate was 32.7+/-12.7 mGy/min. Although 33.2% of ESD was from fluoroscopy in diagnostic procedures, the figure was 68.8% in TAE procedures. It was demonstrated that the increase in ESD during IVR was caused by the rise of fluoroscopy dose rate caused by high-magnification fluoroscopy and the extension of fluoroscopy time. In order to reduce ESD, it is necessary to use a low fluoroscopy dose rate with low-rate pulse fluoroscopy, in addition to shortening fluoroscopy time. Fluoroscopy time was a poor predictor of risk because it did not correlate well with ESD during IVR (diagnostic procedures r(2)= 0.897, IVR r(2)= 0.594). However, ESD correlated well with the product of BMI and fluoroscopy time (diagnostic procedures r(2)= 0.910, IVR r(2)= 0.783). The linear relationship between ESD and the product of BMI and fluoroscopy time provides a simple monitoring mechanism of the ESD delivered to the patient during interventional radiology procedures. This linear relationship needs to be established for other types of interventional procedures.
authors.affiliation: Department of Radiology, Kanazawa University Hospital.
authors.forename: Hiroji
authors.initials: H
authors.lastname: Iida
authors.forename: Junsei
authors.initials: J
authors.lastname: Horii
authors.forename: Mitsuhiro
authors.initials: M
authors.lastname: Chabatake
authors.forename: Etsurou
authors.initials: E
authors.lastname: Taka
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Shimizu
authors.forename: Takashi
authors.initials: T
authors.lastname: Mizushima
mesh_terms: D015901:Angiography, Digital Subtraction; D015992:Body Mass Index; D006528:Carcinoma, Hepatocellular / Q000628:therapy; D004621:Embolization, Therapeutic; D005471:Fluoroscopy; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy; D011829:Radiation Dosage; D011832:Radiation Injuries / Q000517:prevention & control; D011834:Radiation Monitoring / Q000379:methods*; D011835:Radiation Protection / Q000379:methods; D015641:Radiography, Interventional; D012867:Skin; D013997:Time Factors